Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)

Clinical trial NCT05028582 · COMPLETED

Trial details

NCT number: NCT05028582
Sponsor: Arcutis Biotherapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Scalp Psoriasis

Start date: 2021-08-24
Primary completion: 2022-06-03
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.